Primary hepatitis in dogs: A retrospective review (2002-2006)

Journal of Veterinary Internal Medicine

Volumn 23, Issue 1, 2009, Pages 72-80

  Poldervaart, J H ^a   Favier, R P ^a   Penning, L C ^a   Van Den Ingh, T S G A M ^b   Rothuizen, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TCCI Consultancy BV   (Netherlands)

Author keywords

Copper accumulation; Dogs; Primary hepatitis; Prognostic factors; Wsava histopathology criteria

Indexed keywords

ANIMAL; ANIMAL HEPATITIS; ARTICLE; DISEASE COURSE; DOG; DOG DISEASE; FEMALE; MALE; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ANIMALS; DISEASE PROGRESSION; DOG DISEASES; DOGS; FEMALE; HEPATITIS, ANIMAL; MALE; PROGNOSIS; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 61349103109     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0215.x     Document Type: Article

References (50)

1. Van den Ingh TSGAM, Van Winkle TJ, Cullen JM, et al. Morphological classification of parenchymal disorders of the canine and feline liver. In: WSAVA, ed. Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases, 1st ed. Philadelphia, PA: Saunders Elsevier; 2006:85-101.
2. Boomkens SY, Penning LC, Egberink HF, et al. Hepatitis with special reference to dogs. A review on the pathogenesis and infectious etiologies, including unpublished results of recent own studies. Vet Q 2004;26:107-114.
3. Adamus C, Buggin-Daubie M, Izembart A, et al. Chronic hepatitis associated with leptospiral infection in vaccinated Beagles. J Comp Pathol 1997;117:311-328.
4. Chouinard L, Martineau D, Forget C, et al. Use of polymerase chain reaction and immunohistochemistry for detection of canine adenovirus type 1 in formalin-fixed, paraffin-embedded liver of dogs with chronic hepatitis or cirrhosis. J Vet Diagn Invest 1998;10:320-325.
5. Houston DM, Ribble CS, Head LL. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991). J Am Vet Med Assoc 1996;208:542-546.
6. Jarrett WFH, O'Neil BW. A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in dogs. Vet Rec 1985;116:629-635.
7. Jarrett WFH, O'Neil BW, Lindholm I. Persistent hepatitis and chronic fibrosis induced by canine acidophil cell hepatitis virus. Vet Rec 1987;120:234-235.
8. Birnbaum N, Barr SC, Center SA, et al. Naturally acquired leptospirosis in 36 dogs: Serological and clinicopathological features. J Small Anim Pract 1998;39:231-236.
9. Rakich PM, Prasse KW, Lukert PD, et al. Immunohistochemical detection of canine adenovirus in paraffin sections of liver. Vet Pathol 1986;23:478-484.
10. Boomkens SY, Slump E, Egberink HF, et al. PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol 2005;108:49-55.
11. Wagner KA, Hartmann FA, Trepanier LA. Bacterial culture results from liver, gallbladder, or bile in 248 dogs and cats evaluated for hepatobiliary disease: 1998-2003. J Vet Intern Med 2007;21: 417-424.
12. Decaro N, Campolo M, Elia G, et al. Infectious canine hepatitis: An ''old'' disease reemerging in Italy. Res Vet Sci 2007; 83:269-273.
13. Fox JG, Drolet R, Higgins R, et al. Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 1996;34:2479-2482.
14. Bishop L, Strandberg JD, Adams RJ, et al. Chronic active hepatitis in dogs associated with leptospires. Am J Vet Res 1979;40: 839-844.
15. Newberne PM. Chronic aflotoxicosis. J Am Vet Med Assoc 1973;163:1262-1267.
16. Newman SJ, Smith JR, Stenske KA, et al. Aflatoxicosis in nine dogs after exposure to contaminated commercial dog food. J Vet Diagn Invest 2007;19:168-175.
17. Dayrell-Hart B, Steinberg SA, VanWinkle TJ, et al. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc 1991;199:1060-1066.
18. Little CJL, McNeil PE, Robb J. Hepatopathy and dermatitis in a dog associated with the ingestion of mycotoxins. J Small Anim Pract 1991;32:23-26.
19. Twedt DC, Diehl KJ, Lappin MR, et al. Association of hepatic necrosis with trimethoprim sulfonamide administration in 4 dogs. J Vet Intern Med 1997;11:20-23.
20. Chaffee VW, Edds GT, Himes JA, et al. Aflatoxicosis in dogs. Am J Vet Res 1969;30:1737-1749.
21. Bunch SE, Castleman WL, Hornbuckle WE, et al. Hepatic cirrhosis associated with long-term anticonvulsant drug therapy in dogs. J Am Vet Med Assoc 1982;181:357-362.
22. Poffenbarger EM, Hardy RM. Hepatic cirrhosis associated with long-term primidone therapy in a dog. J Am Vet Med Assoc 1985;186:978-980.
23. Andersson M, Sevelius E. Circulating autoantibodies in dogs with chronic liver disease. J Small Anim Pract 1992;33:389-394.
24. Poitout F, Weiss DJ, Armstrong PJ. Cell-mediated immune responses to liver membrane protein in canine chronic hepatitis. Vet Immunol Immunopathol 1997;57:169-178.
25. Thornburg LP. Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers. Vet Pathol 1998;35:380-385.
26. Weiss DJ, Armstrong PJ, Mruthyunjaya A. Anti-liver membrane protein antibodies in dogs with chronic hepatitis. J Vet Intern Med 1995;9:267-271.
27. Rolfe DS, Twedt DC. Copper-associated hepatopathies in dogs. Vet Clin North Am Small Anim Pract 1995;25:399-417.
28. Sevelius E, Andersson M, Jonsson L. Hepatic accumulation of alpha-1-antitrypsin in chronic liver disease in the dog. J Comp Pathol 1994;111:401-412.
29. Sevelius E, Andersson M. Serum protein electrophoresis as a prognostic marker of chronic liver disease in dogs. Vet Rec 1995; 137:663-667.
30. Mandigers PJ, van den Ingh TSGAM, Bode P, et al. Association between liver copper concentration and subclinical hepatitis in Doberman Pinschers. J Vet Intern Med 2004;18:647-650.
31. Webb CB, Twedt DC, Meyer DJ. Copper-associated liver disease in Dalmatians: A review of 10 dogs (1998-2001). J Vet Intern Med 2002;16:665-668.
32. Van de Sluis B, Rothuizen J, Pearson PL, et al. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet 2002;11:165-173.
33. Twedt DC, Sternlieb I, Gilbertson SR. Clinical, morphologic, and chemical studies on copper toxicosis of Bedlington Terriers. J Am Vet Med Assoc 1979;175:269-275.
34. Thornburg LP, Shaw D, Dolan M, et al. Hereditary copper toxicosis in West Highland white terriers. Vet Pathol 1986;23:148-154.
35. Haywood S, Rutgers HC, Christian MK. Hepatitis and copper accumulation in Skye terriers. Vet Pathol 1988;25:408-414.
36. Watson PJ. Chronic hepatitis in dogs: A review of current understanding of the etiology, progression, and treatment. Vet J 2004;167:228-241.
37. Strombeck DR, Miller LM, Harrold D. Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (1977-1985). J Am Vet Med Assoc 1988;193:1109-1113.
38. Shih JL, Keating JH, Freeman LM, et al. Chronic hepatitis in Labrador Retrievers: Clinical presentation and prognostic factors. J Vet Intern Med 2007;21:33-39.
39. Sevelius E. Diagnosis and prognosis of chronic hepatitis and cirrhosis in dogs. J Small Anim Pract 1995;36:521-528.
40. Rothuizen J, Desmet V, van den Ingh TSGAM, et al. Chapter 2: Sampling and handling of liver tissue. In: WSAVA, ed. Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases, 1st ed. Philadelphia, PA: Saunders Elsevier; 2006:5-14.
41. Van den Ingh TS, Rothuizen J, Cupery R. Chronic active hepatitis with cirrhosis in the Doberman Pinscher. Vet Q 1988;10:84-89.
42. Hoffmann G, van den Ingh TS, Bode P, et al. Copper-associated chronic hepatitis in Labrador Retrievers. J Vet Intern Med 2006;20:856-861.
43. Spee B, Arends B, van den Ingh TSGAM, et al. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med 2006;20:1085-1092.
44. Piantadosi S. Prognostic factor analyses. In: Piantadosi S, ed. Clinical Trials: A Methodologic Perspective, 1st ed. New York, NY: Wiley-Interscience; 1997:334-361.
45. Stanworth DR, Hunneyball IM. Influence of D-penicillamine treatment on the humoral immune system. Scand J Rheumatol 1979;28(Suppl):37-46.
46. Harth M, Keown PA, Orange JF. Effects of D-penicillamine on inflammatory and immune reactions. Clin Invest Med 1984;7: 45-51.
47. Epstein O, De Villiers D, Jain S, et al. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med 1979;300:274-278.
48. Hoffmann G, Jones PG, Mesu CJ, et al. Randomized, double-blind, placebo-controlled treatment of hepatic copper accumulation in Labrador Retrievers with penicillamine. J Vet Intern Med 2008; in press.
49. Andersson M, Sevelius E. Breed, sex and age distribution in dogs with chronic liver disease: A demographic study. J Small Anim Pract 1991;32:1-5.
50. Lefkowitch JH. Liver biopsy assessment in chronic hepatitis. Arch Med Res 2007;38:634-643.